Home › Funds › SABBY MANAGEMENT, LLC › CPHI
SABBY MANAGEMENT, LLC position in CPHI
CHINA PHARMA HLDGS INC · Health Care
SABBY MANAGEMENT, LLC reported holding 308,360 shares of CPHI (CHINA PHARMA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$203K, representing 4.50% of its reported portfolio and ranking #9 among its reported holdings. SABBY MANAGEMENT, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SABBY MANAGEMENT, LLC's CPHI position evolved
SABBY MANAGEMENT, LLC first disclosed a stake in CPHI in Q3 2026 at 308,360 shares (US$203K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 308.36K | $202.59K | New |
About CPHI and 13F data
CPHI (CHINA PHARMA HLDGS INC) is a Health Care company. 9 other funds we track also report a position in CPHI. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on SABBY MANAGEMENT, LLC
FAQ
How long has SABBY MANAGEMENT, LLC held CPHI?
SABBY MANAGEMENT, LLC has disclosed CPHI holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SABBY MANAGEMENT, LLC's current position in CPHI?
As of Q3 2026, SABBY MANAGEMENT, LLC holds 308.36K shares of CPHI (CHINA PHARMA HLDGS INC), valued at $202.59K, representing 4.50% of its reported portfolio and ranking #9.
Has SABBY MANAGEMENT, LLC been buying or selling CPHI?
In the latest 13F filing (Q3 2026), SABBY MANAGEMENT, LLC newly opened its position in CPHI.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.